PCPROMI Stock Latest News
Private CompaniesPromise Bio Highlights Epiproteomics Platform for Non‑Invasive Kidney Damage Monitoring1M agoPROMI
Private CompaniesPromise Bio Highlights Functional Proteomics Focus at Biomarkers & CDx Summit1M agoPROMI
Private CompaniesPromise Bio Targets Epiproteomics Demand Ahead of BIO 2026 Convention5M agoPROMI
Private CompaniesPromise Bio Advances Precision Nephrology with Pfizer Data and Bio-IT World Spotlight5M agoPROMI
Private CompaniesPromise Bio Highlights Epiproteomic Kidney Disease Data from Pfizer Collaboration5M agoPROMI
Private CompaniesPromise Bio Showcases Proteome Platform Focus Ahead of Bio-IT World6M agoPROMI
Private CompaniesPromise Bio Showcases Scientific Leadership and AI-Driven IBD Platform in Busy Week7M agoPROMI
Private CompaniesScientific Leadership Recognition Highlights Promise Bio’s Research Profile7M agoPROMI
Private CompaniesExternal Scientific Recognitions Highlight Leadership Strength at Promise Bio7M agoPROMIPrivate CompaniesPromise Bio Highlights AI-Driven Precision Medicine Platform for IBD at DDW7M agoPROMI
Private CompaniesPromise Bio Targets Ground-Truth Challenges in Functional Proteomics7M agoPROMI
Private CompaniesPromise Bio Emphasizes Proteoform-Focused Approach to Advance Functional Proteomics8M agoPROMI
Private CompaniesPromise Bio Advances AI-Driven Epiproteomics Strategy and Targets New Partnerships8M agoPROMIPrivate CompaniesPromise Bio Highlights Epiproteomics and AI Approach in Precision Medicine8M agoPROMI




